{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:37:38Z","timestamp":1773149858015,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.bbrc.2007.10.083","type":"journal-article","created":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T10:07:12Z","timestamp":1193306832000},"page":"801-807","source":"Crossref","is-referenced-by-count":40,"title":["Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient l-amino acid-defined diet"],"prefix":"10.1016","volume":"364","author":[{"given":"Haiyan","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Sakaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2007.10.083_bib1","first-page":"820","article-title":"Natural history of nonalcholic steatohepatitis: a longitudinal study of repeat liver biopsies","volume":"40","author":"Fassio","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/jhep.2002.33324","article-title":"Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis","volume":"35","author":"Ratziu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib4","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.20665","article-title":"Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats","volume":"41","author":"Bataller","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib5","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1053\/gast.2002.36561","article-title":"Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver","volume":"123","author":"Paizis","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/jhep.2001.28231","article-title":"Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats","volume":"34","author":"Yoshiji","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","article-title":"Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II","volume":"125","author":"Bataller","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib9","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies","volume":"328","author":"Friedman","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2007.10.083_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbrc.2007.10.083_bib11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR gamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2007.10.083_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cld.2004.04.002","article-title":"Animal models of nonalcoholic fatty liver disease and steatohepatitis","volume":"8","author":"Nanji","year":"2004","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbrc.2007.10.083_bib13","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/carcin\/15.10.2201","article-title":"Prevention of fibrosis reduces enzyme-altered lesions in the rat liver","volume":"15","author":"Sakaida","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2007.10.083_bib14","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/j.lfs.2004.09.041","article-title":"Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet","volume":"76","author":"Jin","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2007.10.083_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00535-007-2020-5","article-title":"The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis","volume":"42","author":"Jin","year":"2007","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2007.10.083_bib16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1440-1827.1999.00990.x","article-title":"Endogenous liver carcinogenesis in the rat","volume":"49","author":"Nakae","year":"1999","journal-title":"Pathol. Int."},{"key":"10.1016\/j.bbrc.2007.10.083_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840110412","article-title":"Stimulation of hepatic lipocyte collagen prodiction by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis","volume":"11","author":"Matsuoka","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.510300431","article-title":"Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation","volume":"30","author":"Benyon","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib19","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0002-9440(10)65703-3","article-title":"Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis","volume":"153","author":"Kossakowska","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2007.10.083_bib20","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1074\/jbc.M310284200","article-title":"Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells","volume":"279","author":"Hazra","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2007.10.083_bib21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/gast.1996.v110.pm8608892","article-title":"Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver","volume":"110","author":"Benyon","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2007.10.083_bib22","doi-asserted-by":"crossref","first-page":"37731","DOI":"10.1074\/jbc.R100034200","article-title":"PPAR gamma: a nuclear regulator of metabolism, differentiation, and cell growth","volume":"276","author":"Rosen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2007.10.083_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.nutr.22.010402.102808","article-title":"PPAR (gamma) and glucose homeostasis","volume":"22","author":"Picard","year":"2002","journal-title":"Annu. Rev. Nutr."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X07022346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X07022346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T11:25:04Z","timestamp":1546514704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X07022346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0006291X07022346"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2007.10.083","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}